Author: Lupin Pharmaceuticals

HCM & HRIS

Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States

August 18, 2026
Lupin Pharmaceuticals
No Comments

, /PRNewswire/ –Global pharmaceutical leader Lupin Limited (Lupin)(BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today…